Filing Details
- Accession Number:
- 0001358403-16-000207
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-06-06 16:06:12
- Reporting Period:
- 2016-06-02
- Filing Date:
- 2016-06-06
- Accepted Time:
- 2016-06-06 16:06:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1358403 | Bellicum Pharmaceuticals Inc | BLCM | Pharmaceutical Preparations (2834) | 201450200 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1626895 | Ken Moseley | C/O Bellicum Pharmaceuticals, Inc. 2130 W. Holcombe Blvd., Ste. 800 Houston TX 77030 | Sr. Vp And General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-06-02 | 15,000 | $2.55 | 15,196 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-06-02 | 15,000 | $13.00 | 196 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2016-06-02 | 15,000 | $0.00 | 15,000 | $2.55 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 13,823 | 2022-12-31 | No | 4 | M | Direct |
Footnotes
- Includes 99 shares acquired under the Issuer's Employee Stock Purchase Plan on December 10, 2015.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 24, 2015.
- 25% of the shares subject to the stock option vested and became exercisable on January 1, 2014, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter.
Billionaire Hedge Funds
